Loading...
Market
Will Neuralink's N1 Implant trial encounter significant safety issues by Mar 31, 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
FDA reports or Neuralink public statements
Story
Neuralink Launches Trial of N1 Brain Implant to Control Robotic Arm in Paralyzed Patients
Nov 25, 2024, 07:45 PM
Neuralink announced the launch of a new feasibility study, named 'CONVOY', to extend brain-computer interface (BCI) control using the N1 Implant to an investigational assistive robotic arm. The study aims to evaluate the safety and effectiveness of the implant in patients with quadriplegia, allowing them to control external devices with their thoughts. This development represents an important step towards restoring physical freedom to individuals with paralysis.
View original story
Similar markets
Full success • 25%
Partial success • 25%
No success • 25%
Trial discontinued • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Very Positive • 25%
Somewhat Positive • 25%
Neutral • 25%
Negative • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Successful with no issues • 25%
Successful with minor issues • 25%
Unsuccessful due to technical issues • 25%
Unsuccessful due to patient complications • 25%